Close

Shire (SHPG) Says Decentralized Procedure for Immunoglobulin Treatment Cuvitru in Europe Now Complete

June 10, 2016 3:31 PM EDT Send to a Friend
Cuvitru (IG 20mg/ml solution for subcutaneous injection) builds on company's broad portfolio of IG treatments gained through combination with Baxalta ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login